Search research articles
Contact Us
Filters
Showing results (351-360 of 504) with videos related to
Page
of 51
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2019
Prospective Evaluation of PSMA-Targeted <sup>18</sup>F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer
Steven P Rowe, Scott P Campbell, Margarita Mana-Ay, et al.
European Urology
|
April 12, 2021
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
Mohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
Clinical Genitourinary Cancer
|
November 26, 2015
PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?
Steven P Rowe, Margarita Mana-Ay, Mehrbod S Javadi, et al.
Tomography (Ann Arbor, Mich.)
|
August 25, 2023
Detection of Biochemically Recurrent Prostate Cancer with [<sup>18</sup>F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters
Mohammad S Sadaghiani, Sara Sheikhbahaei, Abdullah Al-Zaghal, et al.
The Journal of Urology
|
April 7, 2020
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer
Mark C Markowski, Ramy Sedhom, Wei Fu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 2025
Safety, Dosimetry, and Feasibility of [<sup>68</sup>Ga]Ga-PSMA-R2 as an Imaging Agent in Patients with Biochemical Recurrence or Metastatic Prostate Cancer
Liza Lindenberg, Thomas A Hope, Frank I Lin, et al.
Theranostics
|
January 8, 2019
The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?
Rudolf A Werner, Alexander Weich, Malte Kircher, et al.
Diagnostics (Basel, Switzerland)
|
April 30, 2021
Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer
Wajahat Khatri, Hyun Woo Chung, Rudolf A Werner, et al.
Annals of Nuclear Medicine
|
March 17, 2019
<sup>18</sup>F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies
Sara Sheikhbahaei, Krystyna M Jones, Rudolf A Werner, et al.
The Journal of Biological Chemistry
|
May 12, 2005
Unraveling the mechanism of a potent transcriptional activator
Zhen Lu, Steven P Rowe, Brian B Brennan, et al.
Page
of 51
Search research articles
Search
Showing results (351-360 of 504) with videos related to
Sort By:
Page
of 51
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 16, 2019
Prospective Evaluation of PSMA-Targeted <sup>18</sup>F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer
Steven P Rowe, Scott P Campbell, Margarita Mana-Ay, et al.
European Urology
|
April 12, 2021
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
Mohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
Clinical Genitourinary Cancer
|
November 26, 2015
PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?
Steven P Rowe, Margarita Mana-Ay, Mehrbod S Javadi, et al.
Tomography (Ann Arbor, Mich.)
|
August 25, 2023
Detection of Biochemically Recurrent Prostate Cancer with [<sup>18</sup>F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters
Mohammad S Sadaghiani, Sara Sheikhbahaei, Abdullah Al-Zaghal, et al.
The Journal of Urology
|
April 7, 2020
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer
Mark C Markowski, Ramy Sedhom, Wei Fu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 6, 2025
Safety, Dosimetry, and Feasibility of [<sup>68</sup>Ga]Ga-PSMA-R2 as an Imaging Agent in Patients with Biochemical Recurrence or Metastatic Prostate Cancer
Liza Lindenberg, Thomas A Hope, Frank I Lin, et al.
Theranostics
|
January 8, 2019
The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?
Rudolf A Werner, Alexander Weich, Malte Kircher, et al.
Diagnostics (Basel, Switzerland)
|
April 30, 2021
Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer
Wajahat Khatri, Hyun Woo Chung, Rudolf A Werner, et al.
Annals of Nuclear Medicine
|
March 17, 2019
<sup>18</sup>F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies
Sara Sheikhbahaei, Krystyna M Jones, Rudolf A Werner, et al.
The Journal of Biological Chemistry
|
May 12, 2005
Unraveling the mechanism of a potent transcriptional activator
Zhen Lu, Steven P Rowe, Brian B Brennan, et al.
Page
of 51